Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep341 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Anti-Lipogenic effects of cabergoline: A molecular study on white adipocytes

Negri Mariarosaria , Pivonello Claudia , Amatrudo Feliciana , Gentile Annalisa , Montò Tatiana , Patalano Roberta , Simeoli Chiara , Ferrigno Rosario , Simona Auriemma Renata , Colao Annamaria , Pivonello Rosario

Obesity is caused by an imbalance between dietary energy intake and expenditure. The expression of dopamine receptors (DRs) in human adipocytes has been already demonstrated. Moreover, the effects of cabergoline, a dopamine agonist, on body weight and glucose homeostasis in obese subjects without hyperprolactinemia has already been reported. The current study investigates the effects of cabergoline on lipid accumulation and on adipogenic factors expression to better define the...

ea0032p21 | Adrenal cortex | ECE2013

Bilateral inferior petrosal sinus sampling in cushing's syndrome: comparison between an old and a new technique in naples experience

De Leo Monica , Tortora Fabio , Cozzolino Alessia , Simeoli Chiara , Iacuaniello Davide , Albano Aurora , Briganti Francesco , Cirillo Sossio , Colao Annamaria , Pivonello Rosario

Introduction: Bilateral inferior petrosal sinus sampling (BIPSS) is the test that offers the highest diagnostic accuracy in the differential diagnosis between pituitary and ectopic Cushng’s syndrome (CS). The aim of this study was to compare the diagnostic accuracy of BIPSS performed in the last six years, after the change in the technical procedure with that performed in the past period in Naples centre.Patients and methods: Seventeen patients with...

ea0032p866 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Effects of short (12 months) and long (60 months) term treatment with cabergoline on metabolic syndrome and visceral adiposity index in patients with hyperprolactinemia

Auriemma Renata S , Granieri Luciana , Perone Ylenia , Galdiero Mariano , Grasso Ludovica , Simeoli Chiara , Pivonello Claudia , Gasperi Maurizio , Giordano Carla , Colao Annamaria , Pivonello Rosario

Introduction: Hyperprolactinemia is reportedly associated with an impaired metabolic profile, particularly in patients with concomitant hypogonadism. The current study aimed at investigating the effects of short (12 months) and long (60 months) treatment with cabergoline (CAB) on metabolic complications, metabolic syndrome (MS) prevalence and visceral adiposity index (VAI) in hyperprolactinemic patients.Patients and methods: Seventy-one patients (51 F, 2...

ea0032p917 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Effect of short- and long-term treatment with pasireotide on hemochrome in patients with Cushing's disease

Cozzolino Alessia , Simeoli Chiara , Trementino Laura , De Leo Monica , Vitale Pasquale , Iacuaniello Davide , Albano Aurora , Boscaro Marco , Colao Annamaria , Arnaldi Giorgio , Pivonello Rosario

Introduction: Generously supported by IPSEN)-->Glucocorticoids (GC) have a stimulatory effect on neutrophils and an inhibitory effect on the other leukocyte subpopulations. A potential stimulatory effect on erythropoiesis has been also hypothesized. The aim of our study was to evaluate the effect of pasireotide treatment on hemochrome parameters in patients with endogenous pituitary-dependent glucocorticoid excess or Cushing’s d...

ea0026p298 | Pituitary | ECE2011

Effects of short (6 months) and long (18 months) term treatment with GH-receptor antagonist pegvisomant (PEG) on rhythm disturbances in acromegaly

Auriemma Renata Simona , Pivonello Rosario , De Martino Maria Cristina , Cudemo Giuseppe , Galdiero Mariano , Grasso Ludovica F S , Simeoli Chiara , Colao Annamaria

Aim: To evaluate the effects of short and long-term treatment with PEG on rhythm disturbances in a cohort of acromegalic patients resistant to long-term high-dose therapy with SA.Patients and methods: Thirteen patients (4 M, 9 F, aged 44±9.25 years) entered the study. All patients started PEG at initial dose of 10 mg daily, then increased of 5 mg every 6 weeks on the basis of IGF1 levels, until IGF1 normalisation or until the achievement of the maxi...

ea0056gp34 | Adrenal cortex | ECE2018

Effects of replication of the physiological and non-physiological cortisol rhythm on insulin sensitivity in muscle: a molecular in vitro analysis on synchronized muscular cells

Negri Mariarosaria , Di Gennaro Gilda , Pivonello Claudia , Simeoli Chiara , Vennery Mary Anna , Barbagallo Federica , Iacuaniello Davide , De Martino Maria Cristina , Isidoro Andrea Maria , Colao Annamaria , Pivonello Rosario

Adrenal insufficiency is a rare endocrine disorder characterized by low levels of cortisol associated with increased mortality, also due to inadequate replacement therapy. The replacement with the thrice-daily immediate release hydrocortisone (IRH), in contrast to the once-daily modified-release hydrocortisone (MRH), more appropriately mimicking the physiological circadian rhythm of cortisol (PCRC), is associated with metabolic disorders, mainly due to the non-physiological pe...

ea0056p387 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

The effect of the dopamine agonist cabergoline on insulin sensitivity in the skeletal muscle: an in vitro study in a mouse cell model demonstrating mediation by serotoninergic receptors

Negri Mariarosaria , Pivonello Claudia , Gennaro Gilda Di , Angelis Cristina de , Simeoli Chiara , Iacuaniello Davide , Nettore Immacolata Cristina , Macchia Paolo Emidio , Muscogiuri Giovanna , Colao Annamaria , Pivonello Rosario

Insulin resistance (IR), characterized by an impairment of target tissues to insulin responsiveness, is the core defect preceding diabetes. Preclinical and clinical data have suggested a role for the dopaminergic system in glucose homeostasis control. The aim of the current study was to investigate the role of the dopamine agonist cabergoline (CAB), displaying high affinity for dopamine type 2 (DR2) receptor and low affinity for serotonin receptors (5-HTRs), in the regulation ...

ea0099p286 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

The clock regulator bmal1 mediates the circadian control of gc-dependent skeletal muscle catabolism by driving PI3K (P100α)-GR interaction

Negri Mariarosaria , Pivonello Claudia , Amatrudo Feliciana , Patalano Roberta , Paola Provvisiero Donatella , de Angelis Cristina , Larocca Angelica , Simeoli Chiara , Colao Annamaria , Pivonello Rosario

The transcriptional activator Bmal1, reaching acrophase in the morning and bathyphase in the evening, is the main regulator of circadian clock. A mutual interaction between circadian clock and glucocorticoids (GCs) has been described as well as their implication in muscle metabolism. The current in vitro study aims at investigating Bmal1 involvement in muscle catabolism induced by GCs circadian exposure. To this aim, mouse myocytes C2C12 were serum-shocked to synchron...

ea0099p107 | Pituitary and Neuroendocrinology | ECE2024

Circulating levels of mir-375 in cushing’s disease patients and evaluation of its role in the regulation of sstr2 expression in murine pituitary corticotroph tumor cell model

Pivonello Claudia , Patalano Roberta , Monto Tatiana , Negri Mariarosaria , Amatrudo Feliciana , Provvisiero Donatella , Simeoli Chiara , Di Paola Nicola , Larocca Angelica , Crescenzo Erminio , Colao Annamaria , Pivonello Rosario

In vitro studies suggest that glucocorticoids (GC) long-term exposure downregulates SSTR2 but not SSTR5 expression in human and mouse ACTH-secreting tumor cells (AtT20), limiting the efficacy of octreotide (OCT), a somatostatin-receptor ligand with high affinity for SSTR2, in the treatment of Cushing’s disease (CD). In AtT20, dexamethasone treatment increased miR-375 expression, whose analysis revealed a seed-sequence for SSTR2, supporting the hypothesis that exc...

ea0099p402 | Late-Breaking | ECE2024

Gonadis national registry on gonadal status in pituitary and adrenal disorders: prevalence and characterization of testicular morpho-structural and reproductive alterations in male patients with congenital adrenal hyperplasia

Menafra Davide , Ferrari Davide , Rastrelli Giulia , de Angelis Cristina , Minnetti Marianna , Simeoli Chiara , Vignozzi Linda , Corona Giovanni , Isidori Andrea , Pivonello Rosario

Congenital adrenal hyperplasia (CAH) is a disorder due to mutations of genes coding for adrenal steroidogenesis enzymes, commonly caused by 21α-hydroxylase enzyme deficiency. Severe impairment of 21α-hydroxylase synthesis results in the classic form of CAH (c-CAH) characterized by cortisol and aldosterone deficiency (salt wasting form - SW), or partial enzyme deficiency characterized by cortisol deficiency (simple virilizing form - SV); mild impairment of 21α-hy...